Arbutus Biopharma Corp
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $200.2M | $36.9M |
| FY2019 | — | $72.7M | $31.8M |
| FY2020 | — | $102.0M | $52.3M |
| FY2021 | $0 | $169.4M | $109.3M |
| FY2022 | $0 | $136.9M | $30.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $200.2M | $36.9M |
| FY2019 | — | $72.7M | $31.8M |
| FY2020 | — | $102.0M | $52.3M |
| FY2021 | $0 | $169.4M | $109.3M |
| FY2022 | $0 | $136.9M | $30.8M |